
An international team of researchers led by Dr. Eleanor Fish, Scientist Emeritus at the Toronto General Hospital Research Institute, UHN, and professor in the University of Toronto‘s Department of Immunology, has shown for the first time that an antiviral drug can help speed up the recovery of COVID-19 patients.
According to the new study, published Friday in Frontiers in Immunology, treatment with interferon(IFN)- a2b may significantly accelerate virus clearance and reduce levels of inflammatory proteins in COVID-19 patients.
The research team found that treatment with this drug, which has been used clinically for many years, significantly reduced the duration of detectable virus in the upper respiratory tract, on average by about seven days. It also reduced blood levels of interleukin(IL)-6 and C-reactive protein (CRP), two inflammatory proteins found in COVID-19 patients.
Dr. Fish says the research team considered IFN-a therapy for COVID-19 after they demonstrated interferon provided therapeutic benefit during the SARS outbreak of 2002 and 2003.
“Rather than developing a virus-specific antiviral for each new virus outbreak, I would argue that we should consider interferons as the ‘first responders’ in terms of treatment,” says Dr. Fish.
“Interferons have been approved for clinical use for many years, so the strategy would be to ‘repurpose’ them for severe acute virus infections.”
Boosting a natural defence mechanism
Interferons are a group of signaling proteins released by the human body in response to all viruses. As Dr. Fish explains, they are a “first line of defence.”
They target different stages of a virus’s life cycle, inhibiting them from multiplying. They also boost an immune response by activating different immune cells to clear an infection. Some viruses, however, can block this natural defense mechanism.
“But it is possible to override this block. If a virus blocks interferon production, then treating with interferon can offset this.”
Study details
The researchers conducted this exploratory study on a group of 77 patients with COVID-19 in Wuhan, China. These patients were admitted to Union Hospital, Tongii Medical College, between January 16 and February 20, 2020. They represented moderate cases of the disease as none of the patients required intensive care or prolonged oxygen supplementation or intubation.
Despite the study’s limitations of a small, non-randomized group of patients, the work provides several important and novel insights into COVID-19 disease, notably that treatment with IFN-a2b can accelerate viral clearance from the upper respiratory tract and also reduce circulating levels of inflammatory factors that are associated with severe COVID-19.
Dr. Fish says a randomized clinical trial is a crucial next step. According to her, a clinical trial with a larger group of infected patients who are randomized to treatment or placebo would further this research.
In the meantime, the findings from this study are the first to suggest therapeutic efficacy of IFN-a2b as an available antiviral intervention for COVID-19, which may also benefit public health measures by shortening the duration of viral clearance and therefore slowing the tide of the pandemic.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Recovery of COVID-19 patients
- Oil prices advance on U.S. growth, Chinese recovery hope
Oil prices edged ahead for a second session on Friday, buoyed by stronger-than-expected U.S. economic growth and hopes of a rapid recovery in Chinese demand as COVID-19 cases and deaths plunged from ...
- AdventHealth Orlando launches new clinic for COVID-19 long-haulers
Fennimore was referred to a brand-new post-COVID-19 clinic opened at AdventHealth Orlando led by Dr. Dwayne Gordon. "Long-haul COVID is a constellation of symptoms that is not explained by an ...
- No Covid-19 death in 24hrs, positivity rate 0.77pc
No Covid-19 death was reported in 24 hours till 8:00am yesterday, according to a press release issued by the Directorate General of Health Services.
- COVID-19: Maharashtra logs 12 new cases, one death; active tally 94
Maharashtra on Thursday reported 12 new coronavirus positive cases, taking its overall infection tally to 81,37,100, the state health department said. An administrative circle comprises multiple ...
- Coronavirus updates for Jan. 26: Here’s what to know in North Carolina this week
At least 12,862 new coronavirus cases were reported in North Carolina last week, down from 15,219 the week before, according to preliminary data from state health officials. The N.C. Department of ...
Go deeper with Google Headlines on:
Recovery of COVID-19 patients
[google_news title=”” keyword=”recovery of COVID-19 patients” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Antiviral drug
- Tonix Pharmaceuticals Announces Presentation of Licensed Antiviral Drug Technology at the 2nd Wnt & β-catenin Targeted Drug Development Conference
Oral Presentation Describes Activity of Wnt/β-catenin Signaling Pathway Inhibitors Against SARS-CoV-2 in Cell Culture and in an Animal ModelCHATHAM, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: ...
- Cocrystal Pharma Discusses Clinical Progress and Significance of Its Novel Antiviral Therapeutics Pipeline with The Stock Day Podcast
The Stock Day Podcast welcomed Cocrystal Pharma, Inc. (NASDAQ: COCP) ("Cocrystal," "Cocrystal Pharma" or "the Company"), a clinical-stage biotechnology company discovering and developing novel ...
- Rural China runs short of Covid drugs over lunar new year holiday
Relatives in Shanghai rushed to send antiviral drugs by post after the local hospital and clinic ran out of supplies, but when the medicine arrived, Wu’s mother had already tested negative.
- Shingles Raises Stroke Risk for Seniors, but Antiviral Drugs Help
However, this risk can be reduced if they’re treated with oral antiviral drugs, according to a new study published online in Clinical Infectious Diseases. According to the study, conducted by ...
- How antiviral drugs could be the next weapon against coronavirus
There's also the matter of technology, given how hard these drugs are to make. Modern technology allows scientists to digitally screen for chemicals with coronavirus-destroying effects to help ...
Go deeper with Google Headlines on:
Antiviral drug
[google_news title=”” keyword=”antiviral drug” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]